Pressure BioSciences evaluating AI, ML prospective partnerships

Pressure BioSciences announced they are actively pursuing and evaluating multiple artificial intelligence and machine learning prospective partnerships. The Company expects such collaborations to accelerate the identification and prioritization of exciting commercial product opportunities within key markets for PBIO‘s patented BaroFold Technology and Ultra Shear Technology platforms. BaroFold employs high pressure for the disaggregation and controlled refolding of proteins to their desired native structures to significantly improve the quality and production costs of protein therapeutics. UltraShear uses intense shear forces from ultra-high pressure valve discharge to turn oil-based supplements, therapeutics, and other water-insoluble active ingredients into stable, effectively water-soluble, highly bioavailable nanoemulsions. A major PBIO goal in 2024 is to employ AI/ML tools to address a critical challenge – understanding protein folding kinetics to predict the optimal chemical environment for high-pressure refolding. This groundbreaking approach will greatly streamline biopharmaceutical R&D, resulting in more efficient, efficacious, and cost-effective processes and products.